Unique ID issued by UMIN | UMIN000036329 |
---|---|
Receipt number | R000041302 |
Scientific Title | Multicenter randomized trial to evaluate the efficacy of compression therapy with Elastic Compression Gloves and Stockings for prevention of chemotherapy-induced neuropathy in breast cancer patients |
Date of disclosure of the study information | 2019/06/01 |
Last modified on | 2020/08/25 14:47:30 |
Multicenter randomized trial to evaluate the efficacy of compression therapy with Elastic Compression Gloves and Stockings for prevention of chemotherapy-induced neuropathy in breast cancer patients
RCT of compression therapy with ECGS for prevention of CIPN
Multicenter randomized trial to evaluate the efficacy of compression therapy with Elastic Compression Gloves and Stockings for prevention of chemotherapy-induced neuropathy in breast cancer patients
RCT of compression therapy with ECGS for prevention of CIPN
Japan |
Breast Cancer
Hematology and clinical oncology | Breast surgery |
Malignancy
NO
evaluate the efficacy of compression therapy with Elastic Compression Gloves and Stockings for prevention of chemotherapy-induced neuropathy in breast cancer patients
Safety,Efficacy
Confirmatory
Pragmatic
Phase III
1)Score of hands in Patient Neurotoxicity Questionnaire (PNQ) until 12cycle Day8
2)CTCAE grade of hands in until 12cycle Day8
3)Score of feet in Patient Neurotoxicity Questionnaire (PNQ) until 12cycle Day8
4)CTCAE grade of feet in until 12cycle Day8
1)Time to PNQ score D
2)Time to CTCAE grade 2
3)Grooved pegboard test
4) Semmes-Weinstein monofilament
Test
5)Skin and subcutaneous tissue disorders (CTCAE grade2)
6)Temperature of hands and feet before and after compression
7)Ratio of cases dropping out
8)CIPN 6,12,18,24months after cycle12
9)Pressure of ECGS
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
YES
NO
Institution is not considered as adjustment factor.
NO
No need to know
2
Prevention
Device,equipment |
Compression therapy with Elastic Compression Gloves and Stockings(ECGS) to the hand and the foot of intervention side:wearing ECGS to the intervention side in all 12 cycles from 30 minutes before administration of paclitaxel therapy to 30 minutes after administration
No prevention on the control side
20 | years-old | <= |
75 | years-old | >= |
Female
Breast cancer patients planning to receive more than 12cycles of weekly Paclitaxel therapy
Patients who have CTCAE more than grade1 neuropathy and/or skin disorders
100
1st name | Nobuko |
Middle name | |
Last name | Kawaguchi |
Kyoto University
Clinical Oncology
6068507
54 Shogoin Kawara-cho Sakyo-ku, Kyoto
075-751-3660
nobuko75@kuhp.kyoto-u.ac.jp
1st name | Kazuo |
Middle name | |
Last name | Sakamoto |
General Incorporated Association Kyoto Breast Cancer Research Network
KBCRN Study Office
6018001
1-10 Higashikuzyoumuromachi Minami-ku,Kyoto
075-585-7861
info@kyoto-breast-cancer.org
KBCRN Study Office
Japan Agency of Medical Research and Development(AMED)
Japanese Governmental office
Japan
Japan Society of Clinical Oncology
Kyoto University Certified Review Board
Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, JAPAN
075-753-4680
ethcom@kuhp.kyoto-u.ac.jp
NO
京都大学医学部附属病院(京都府)
大阪赤十字病院(大阪府)
兵庫県立尼崎総合医療センター(兵庫県)
神戸市立医療センター中央病院(兵庫県)
天理よろづ相談所病院(奈良県)
日本赤十字社和歌山医療センター(和歌山県)
神鋼記念病院(兵庫県)
田附興風会医学研究所北野病院(大阪府)
2019 | Year | 06 | Month | 01 | Day |
Unpublished
0
Because we decided to change the plan and conduct the clinical research based on it.
2020 | Year | 08 | Month | 25 | Day |
Terminated
2019 | Year | 03 | Month | 13 | Day |
2019 | Year | 03 | Month | 13 | Day |
2019 | Year | 06 | Month | 15 | Day |
2023 | Year | 06 | Month | 14 | Day |
2019 | Year | 03 | Month | 28 | Day |
2020 | Year | 08 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041302
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |